Skip to content

The Effect of Iloprost on Oxygenation During One-lung Ventilation for Lung Surgery

The Effect of Iloprost on Arterial Oxygenation and Shunt Fraction During One-lung Ventilation for Lung Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03936140
Enrollment
72
Registered
2019-05-03
Start date
2018-01-04
Completion date
2018-10-24
Last updated
2019-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

During one-lung ventilation in patients undergoing thoracic surgery, the persistent flow in the non-ventilated lung increases intrapulmonary shunt and decreases systemic arterial oxygenation. This prospective, randomized, double blind study was conducted to evaluate the effects of inhaled iloprost during one-lung ventilation on arterial oxygenation and shunt fraction during thoracic surgery.

Interventions

Study drug was inhaled to ventilated lung through a nebulized system in inspiratory limb after one-lung ventilation in the lateral decubitus position.

DRUGDistilled water

Study drug was inhaled to ventilated lung through a nebulized system in inspiratory limb after one-lung ventilation in the lateral decubitus position.

Sponsors

The Catholic University of Korea
CollaboratorOTHER
Seoul St. Mary's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* elective video-assisted thoracoscopic surgery (VATS) lobectomy * 20 \< age \< 75 * American Society of Anesthesiologists (ASA) classification I\ III

Exclusion criteria

* ASA classification IV * New York Heart Association (NYHA) class III\ IV * Severe obstructive lung disease / restrictive lung disease * Pulmonary hypertension * End-stage organ disease (i.e. hepatic failure, renal failure) * Arrhythmia * Previous history of thoracic surgery

Design outcomes

Primary

MeasureTime frameDescription
PaO2(partial pressure of arterial oxygen)30 min after treatmentABGA
Pulmonary shunt fraction30 min after treatmentQs/Qt = (CcO2-CaO2) / (CcO2-CvO2)

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026